-
5 Stock in Different Moves: Microsoft Corporation (NASDAQ:MSFT), The Dow Chemical (NYSE:DOW), Lexmark International (NYSE:LXK), Oncothyreon (NASDAQ:ONTY), Stanley Black & Decker (NYSE:SWK)
Microsoft Corporation (NASDAQ:MSFT) said it has released its Skype 7 for Windows with improved features following complaints from users regarding its screen space that the app consumes. Microsoft Corporation (NASDAQ:MSFT) in last trading activity fell -0.86% to close at $48.42. Company weekly performance is 1.28% while its quarterly performance stands at 4.85%. Microsoft Corporation (NASDAQ:MSFT)…
-
Morning Alert: Oncothyreon Inc (NASDAQ:ONTY), Goldcorp Inc. (NYSE:GG), RealNetworks Inc. (NASDAQ:RNWK), Eastman Kodak Co. (NYSE:KODK), First Bancshares Inc. (NASDAQ:FBMS)
Oncothyreon Inc. (NASDAQ:ONTY) and Celldex Therapeutics, Inc., (CLDX) on 10 November announced that they have initiated a combined clinical trial of ONT-10 and varlilumab. ONT-10 is a therapeutic vaccine targeting the tumor-associated antigen MUC1. Varlilumab is a fully human monoclonal antibody that targets CD27, a critical molecule in the activation pathway of lymphocytes. Oncothyreon Inc…
-
Microcap Gainers: Viggle Inc. (NASDAQ:VGGL), Idera Pharmaceuticals (NASDAQ:IDRA), Oncothyreon Inc (NASDAQ:ONTY), Coronado Biosciences (NASDAQ:CNDO), E2open (NASDAQ:EOPN)
Viggle Inc. (NASDAQ:VGGL) on Nov. 12 reported strong double-digit growth in its key operating and financial metrics. Revenue grew 49 percent from $4.338 million to $6.476 million in F1Q 2015. Sequential quarterly revenue grew 22 percent from $5.308 million in F4Q 2014. For F1Q 2015, Viggle reported an Adjusted EBITDA loss of $7.8 million as…
-
Hot Biotech Gainers: Idera Pharmaceuticals (NASDAQ:IDRA), Oncothyreon Inc (NASDAQ:ONTY), Coronado Biosciences (NASDAQ:CNDO), Prosensa Holding N.V. (NASDAQ:RNA), NewLink Genetics Corporation (NASDAQ:NLNK)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) on Nov. 7 reported financial results and business highlights for the third quarter of 2014. As of September 30, 2014, Idera’s cash, cash equivalents and investments totaled $58.3 million compared to $35.6 million as of December 31, 2013. Net loss applicable to common stockholders for the three months ended September 30,…
-
Trending Tickers: JPMorgan Chase & Co. (NYSE:JPM), Phoenix New Media Limited (NYSE:FENG), Apollo Global Management, LLC (NYSE:APO), Oncothyreon (NASDAQ:ONTY), Seagate Technology (NASDAQ:STX)
JPMorgan Chase & Co. (NYSE:JPM), the biggest arranger of corporate debt this year, raised Eskom Holdings SOC Ltd.’s debt to buy, saying the South African utility’s yields are attractive and betting its rating won’t be cut further. JPMorgan Chase & Co. (NYSE:JPM) in last trading activity advanced 0.55% to close at $60.45. Company weekly performance…
-
Hot Biotech Gainers: Illumina Inc. (NASDAQ:ILMN), NewLink Genetics Corporation (NASDAQ:NLNK), Oncothyreon Inc (NASDAQ:ONTY), Agios Pharmaceuticals(NASDAQ:AGIO), Sage Therapeutics(NASDAQ:SAGE)
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for Q3 2014 on Monday and beat analyst expectations. The company reported revenue of $481 million, above the average estimates of $451.2 million and a 35 percent increase compared to $357 million in the third quarter of 2013. GAAP net income for the quarter was $93 million, or…
-
Morning Buzz: Costco Wholesale (NASDAQ:COST), Gerdau (NYSE:GGB), NeoPhotonics Corporation (NYSE:NPTN), Hess Corporation (NYSE:HES), Oncothyreon Inc (NASDAQ:ONTY)
Costco Wholesale Corporation (NASDAQ:COST) reported net sales of $8.8 billion for the month of August, the four weeks ended August 31, 2014, an increase of ten percent from $8.0 billion during the similar period last year. Costco Wholesale Corporation (NASDAQ:COST) in last trading activity advanced 3.13% to close at $125.15. Company weekly performance is 3.23%…